SLU-PP-332 (5 mg Vial)

Complete dosage protocol and reconstitution guide for SLU-PP-332 (5 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
SLU-PP-332 (5 mg Vial)

CAT No:

CAS No:

Synonyms/Alias:SLU-PP-332

M.F/Formula:

M.W/Mr.:

Purity:Specification by inquiry

Custom Peptide Support
  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

Complete dosage protocol and reconstitution guide for SLU-PP-332 (5 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.

Quickstart

Evidence Base: Preclinical only—in vivo mouse studies with intraperitoneal dosing (25–50 mg/kg twice daily).

Reconstitute: Add 3.0 mL bacteriostatic water → ~ 1.67 mg/mL concentration.

Murine dose range: 1250–2500 mcg daily (for a 25 g mouse), administered in two divided doses.

Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 insulin syringe.

Storage: Lyophilized: −20 °C (−4 °F) ; reconstituted: 2–8 °C (35.6–46.4 °F) .

Notes

Research compound considerations. No human data: SLU-PP-332 has not been tested in human subjects; all evidence is from murine models. Use new sterile syringes for each administration; dispose in a sharps container. Rotate injection sites to reduce local irritation. Document administration times, doses, and any observations. This compound is for research purposes only—not for human consumption .

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Source URL
https://peptide.cn.com/single-peptide-dosages/slu-pp-332-5-mg-vial-dosage-protocol
Weeks 1–2
Daily Dose (mcg): 1250 mcg | Per-Injection Dose (mcg): 625 mcg | Units per Injection (mL): 37.5 units (0.375 mL)
Weeks 3–8
Daily Dose (mcg): 2500 mcg | Per-Injection Dose (mcg): 1250 mcg | Units per Injection (mL): 75 units (0.75 mL)
Long-term Storage Conditions
Lyophilized: −20 °C (−4 °F) ; reconstituted: 2–8 °C (35.6–46.4 °F) .
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (SLU-PP-332, 5 mg each): 8 weeks ≈ 25 vials

12 weeks ≈ 39 vials

16 weeks ≈ 53 vials

Insulin Syringes (U-100): Per week: 14 syringes (2/day)

8 weeks: 112 syringes

12 weeks: 168 syringes

16 weeks: 224 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution. 8 weeks (25 vials): 75 mL → 8 × 10 mL bottles

12 weeks (39 vials): 117 mL → 12 × 10 mL bottles

16 weeks (53 vials): 159 mL → 16 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each administration. Per week: 28 swabs (4/day)

8 weeks: 224 swabs → recommend 3 × 100-count boxes

12 weeks: 336 swabs → recommend 4 × 100-count boxes

16 weeks: 448 swabs → recommend 5 × 100-count boxes

Product Gallery
Quick Inquiry
Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsApp Mia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China